MedPath

The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis

Not Applicable
Completed
Conditions
Sexual Dysfunction
Endometriosis
Interventions
Registration Number
NCT04287205
Lead Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Brief Summary

This study aimed to assess the effects of dydrogesterone on sexual function in women with endometriosis using Female Function Sexual Index (FSFI).

Detailed Description

Sexual dysfunction is an important outcome for patients with endometriosis. In this study, we compare the fsfi (female sexual function index) questions and the scores before and after dydrogesterone treatment in patients with endometriosis. We aim to measure the effect of dydrogesterone in patients with endometriosis.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
79
Inclusion Criteria
  • no history of malignancies,
  • normal findings at gynecological examinations and transvaginal ultrasonography
  • normal uterine size, normal cervical smear results,
  • patients not use any contraception methods in the last 6 months
Exclusion Criteria
  • with a history of systemic and/or psychiatric diseases,
  • gynecological pathologies (myoma uteri, endometriosis, uterine anomalies, existing genital infections)
  • pelvic organ prolapse
  • pelvic surgeries

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
women with endometriosisDydrogesterone-
Primary Outcome Measures
NameTimeMethod
The Effect of Dydrogesterone on Sexual Function6 months

In this study, we compare the fsfi(female sexual function index) questions and the scores before and after dihydrogestreone treatment in patients with endometriosis. We aim to measure the effect of dihydrogesterone in patients with endometriosis.

Secondary Outcome Measures
NameTimeMethod
The Effect of Dydrogesterone on Sexual Function in women with endometrioma6 months

In this study, we compare the fsfi(female sexual function index) questions and the scores before and after dihydrogestreone treatment in patients with endometriosis. We aim to measure the effect of dihydrogesterone in patients with endometriosis.(with and without endometrioma)

Trial Locations

Locations (1)

Pinar Yalcin Bahat

🇹🇷

Istanbul, İ̇stanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath